Exact Mass: 379.1242076000001
Exact Mass Matches: 379.1242076000001
Found 348 metabolites which its exact mass value is equals to given mass value 379.1242076000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Angoline
C22H21NO5 (379.14196560000005)
Angoline is a benzophenanthridine alkaloid. Angoline is a natural product found in Bocconia arborea, Zanthoxylum zanthoxyloides, and other organisms with data available. Angoline is a potent and selective IL6/STAT3 signaling pathway inhibitor with an IC50 of 11.56 μM. Angoline inhibits STAT3 phosphorylation and its target gene expression, and inhibits cancer cell proliferation[1].
S-Lactoylglutathione
C13H21N3O8S (379.10493060000005)
S-Lactoylglutathione is a substrate of lactoylglutathione lyase [EC 4.4.1.5] in pyruvate metabolism (KEGG). Another enzyme, glyoxalase I, synthesizes this compound by converting methylglyoxal and reduced glutathione to S-lactoylglutathione. S-D-lactoylglutathione can be hydrolysed by thiolesterases to reduced glutathione and D-lactate but also converted to N-D-lactoylcysteinylglycine and N-D-lactoylcysteine by gamma-glutamyl transferase and dipeptidase (PMID: 8632674). S-lactoylglutathione has also been shown to modulate microtubule assembly (PMID: 690442). [HMDB]. S-Lactoylglutathione is found in many foods, some of which are blackcurrant, oat, pomegranate, and brussel sprouts. S-Lactoylglutathione is a substrate of lactoylglutathione lyase [EC 4.4.1.5] in pyruvate metabolism (KEGG). Another enzyme, glyoxalase I, synthesizes this compound by converting methylglyoxal and reduced glutathione to S-lactoylglutathione. S-D-lactoylglutathione can be hydrolysed by thiolesterases to reduced glutathione and D-lactate but also converted to N-D-lactoylcysteinylglycine and N-D-lactoylcysteine by gamma-glutamyl transferase and dipeptidase (PMID: 8632674). S-lactoylglutathione has also been shown to modulate microtubule assembly (PMID: 690442). Acquisition and generation of the data is financially supported in part by CREST/JST. D000970 - Antineoplastic Agents KEIO_ID L016; [MS3] KO009026 KEIO_ID L016; [MS2] KO009024 KEIO_ID L016
kasugamycin
C14H25N3O9 (379.15907200000004)
An amino cyclitol glycoside that is isolated from Streptomyces kasugaensis and exhibits antibiotic and fungicidal properties.
N-methyl-2,3,7,8-tetramethoxybenzophenanthridine-6(5H)-one
C22H21NO5 (379.14196560000005)
Gonyautoxin V
Gonyautoxin V is found in mollusks. Gonyautoxin V is produced by Gonyaulax and Protogonyaulax species. Production by Gonyaulax and Protogonyaulax subspecies Gonyautoxin V is found in mollusks. D009676 - Noxae > D011042 - Poisons > D008978 - Mollusk Venoms D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D011042 - Poisons > D014688 - Venoms
Hyaluronan biosynthesis, precursor 1
This compound belongs to the family of N-acyl-alpha-hexosamines. These are carbohydrate derivatives containing a hexose moeity in which the oxygen atom is replaced by an n-acyl group.
droperidol
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AD - Butyrophenone derivatives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C323 - Butyrophenone D005765 - Gastrointestinal Agents > D000932 - Antiemetics CONFIDENCE standard compound; INTERNAL_ID 1207 INTERNAL_ID 1207; CONFIDENCE standard compound CONFIDENCE standard compound; EAWAG_UCHEM_ID 3679 Droperidol is a butyrophenone-type Dopamine-2 receptor antagonist.
Droperidol
A butyrophenone with general properties similar to those of haloperidol. It is used in conjunction with an opioid analgesic such as fentanyl to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon. It is also used as a premedicant, as an antiemetic, and for the control of agitation in acute psychoses. (From Martindale, The Extra Pharmacopoeia, 29th ed, p593) D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AD - Butyrophenone derivatives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C323 - Butyrophenone D005765 - Gastrointestinal Agents > D000932 - Antiemetics Droperidol is a butyrophenone-type Dopamine-2 receptor antagonist.
2-(Arabinosylamino)-3-(glucosylamino)propanenitrile
C14H25N3O9 (379.15907200000004)
2-(Arabinosylamino)-3-(glucosylamino)propanenitrile is found in pulses. 2-(Arabinosylamino)-3-(glucosylamino)propanenitrile is a constituent of the seeds of Lathyrus sativus (chickling pea). Constituent of the seeds of Lathyrus sativus (chickling pea). 2-(Arabinosylamino)-3-(glucosylamino)propanenitrile is found in pulses.
(R)-S-lactoylglutathionate(1-)
C13H21N3O8S (379.10493060000005)
(R)-S-lactoylglutathionate(1-) is also known as (R)-S-Lactoylglutathionic acid anion. (R)-S-lactoylglutathionate(1-) is considered to be slightly soluble (in water) and acidic
Griseolic acid
Desmethyl Erlotinib
C21H21N3O4 (379.15319860000005)
2H-1-Benzopyran-2-one, 7-[[2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]oxy]-4-methyl-
2-({6-Amino-3,5-dicyano-4-[4-(cyclopropylmethoxy)phenyl]pyridin-2-yl}sulfanyl)acetamide
D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058913 - Purinergic Agonists BAY 60-6583 is a potent and high-affinity agonist of adenosine A2B receptor (EC50?= 3 nM) over A1, A2A, and A3 receptors. BAY 60-6583 binds to mouse, rabbit, and dog A2BAR with Ki values of 750 nM, 340 nM and 330 nM, respectively. BAY 60-6583 has a cardioprotective effect in a myocardial ischemia model[1][5].
Dimethane sulfonate
Licofelone
C23H22ClNO2 (379.13389820000003)
D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents Licofelone (ML-3000) is a dual COX/5-lipoxygenase (5-LOX) inhibitor (IC50=0.21/0.18 μM, respectively) for the treatment of osteoarthritis. Licofelone exerts anti-inflammatory and anti-proliferative effects. Licofelone induces apoptosis, and decreases the production of proinflammatory leukotrienes and prostaglandins[1][2][3].
Merafloxacin
C19H23F2N3O3 (379.17073919999996)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic
2-Amino-5-[[1-[carboxymethyl(2-hydroxypropanoyl)amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid
C13H21N3O8S (379.10493060000005)
Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-
C15H20F3N3O3S (379.11774060000005)
2-(4-(3-Ethynylanilino)-6-(2-methoxyethoxy)quinazolin-7-yl)oxyethanol
C21H21N3O4 (379.15319860000005)
2-(4-(2-Methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide
Bocconoline
C22H21NO5 (379.14196560000005)
Bocconoline is a natural product found in Zanthoxylum asiaticum, Zanthoxylum simulans, and other organisms with data available.
12-Hydroxydihydrochelirubine
A benzophenanthridine alkaloid comprising dihydrochelirubine carrying a hydroxy substituent at the 12-position.
L-gamma-Glutamyl-S-4-(2-hydroxybutyl)-L-cysteinyl-glycine
This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 16HP2005 to the Mass Spectrometry Society of Japan.
L-gamma-Glutamyl-S-3-(1-hydroxybutyl)-L-cysteinyl-glycine
This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 16HP2005 to the Mass Spectrometry Society of Japan.
2-(4-Hydroxyphenyl)-2-(5-oxopyrrolidine-2-yl)-4-(3,4-dihydroxyphenyl)-4-cyclopentene-1,3-dione
6-methoxy-13-methyl-13,14-dihydro-[1,3]dioxolo[4,5-i][1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-14-ol|Chelirubin|chelirubine
12-hydroxy-4-methyl-8,11,15-trioxo-19H-(13betaH)-4,8-seco-crotalanane-14beta-carboxylic acid lactone|14-carboxy-8,12-dihydroxy-4alpha-methyl-11,15-dioxo-(13betaH,14betaH)-14,19-dihydro-crotalananium betaine 12-lactone|Retusamin|retusamine
bruceolline M
An indole alkaloid that is 1H-indole substituted by a 3-hydroxy-3-methyl-2-oxobutyl group at position 3 and a beta-D-glucopyranosyl group attached to the indolic nitrogen. It has been isolated from the ethanol extract of the stems of Brucea mollis.
1,2,4-Trimethoxy-12,13-dihydro-12-methyl[1,3]benzodioxolo[5,6-c]phenanthridine
C22H21NO5 (379.14196560000005)
2-deoxy-N-glycoloyl-9-O-lactoyl-2,3-didehydroneuraminic acid
4-(9H-beta-carbolin-1-ylmethyl)-5-(1-hydroxy-ethyl)-6-oxo-1,4,5,6-tetrahydro-pyridine-3-carboxylic acid methyl ester|Hydroxylyalidin|Hydroxylyalidine
C21H21N3O4 (379.15319860000005)
Licofelone
C23H22ClNO2 (379.13389820000003)
D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents Licofelone (ML-3000) is a dual COX/5-lipoxygenase (5-LOX) inhibitor (IC50=0.21/0.18 μM, respectively) for the treatment of osteoarthritis. Licofelone exerts anti-inflammatory and anti-proliferative effects. Licofelone induces apoptosis, and decreases the production of proinflammatory leukotrienes and prostaglandins[1][2][3].
(E)-1-(L-cysteinylglycin-S-yl)-N-hydroxy-omega-(methylsulfanyl)nonan-1-imine
C24H17N3O2_(7Z)-7-Benzylidene-6-methyl-6,7-dihydroquinazolino[3,2-a][1,4]benzodiazepine-5,13-dione
Hymecromone, O-(2-Acetamido-2-deoxy-beta-D-glucopyranoside)
Coumarins
Cys Gly Asn Ser
C12H21N5O7S (379.11616360000005)
Cys Gly Ser Asn
C12H21N5O7S (379.11616360000005)
Cys Asn Gly Ser
C12H21N5O7S (379.11616360000005)
Cys Asn Ser Gly
C12H21N5O7S (379.11616360000005)
Cys Ser Gly Asn
C12H21N5O7S (379.11616360000005)
Cys Ser Asn Gly
C12H21N5O7S (379.11616360000005)
Gly Cys Asn Ser
C12H21N5O7S (379.11616360000005)
Gly Cys Ser Asn
C12H21N5O7S (379.11616360000005)
Gly Asn Cys Ser
C12H21N5O7S (379.11616360000005)
Gly Asn Ser Cys
C12H21N5O7S (379.11616360000005)
Gly Ser Cys Asn
C12H21N5O7S (379.11616360000005)
Gly Ser Asn Cys
C12H21N5O7S (379.11616360000005)
Asn Cys Gly Ser
C12H21N5O7S (379.11616360000005)
Asn Cys Ser Gly
C12H21N5O7S (379.11616360000005)
Asn Gly Cys Ser
C12H21N5O7S (379.11616360000005)
Asn Gly Ser Cys
C12H21N5O7S (379.11616360000005)
Asn Ser Cys Gly
C12H21N5O7S (379.11616360000005)
Asn Ser Gly Cys
C12H21N5O7S (379.11616360000005)
Ser Cys Gly Asn
C12H21N5O7S (379.11616360000005)
Ser Cys Asn Gly
C12H21N5O7S (379.11616360000005)
Ser Gly Cys Asn
C12H21N5O7S (379.11616360000005)
Ser Gly Asn Cys
C12H21N5O7S (379.11616360000005)
Ser Asn Cys Gly
C12H21N5O7S (379.11616360000005)
Ser Asn Gly Cys
C12H21N5O7S (379.11616360000005)
Chondroitin
2-(Arabinosylamino)-3-(glucosylamino)propanenitrile
C14H25N3O9 (379.15907200000004)
Angiotensin I-Converting Enzyme (ACE) Inactivator
C21H21N3O4 (379.15319860000005)
7-FLUORO-3,4-DIHYDRO-4-[(5-ISOQUINOLINYLOXY)ACETYL]-3,3-DIMETHYL-2(1H)-QUINOXALINONE
C21H18FN3O3 (379.13321299999996)
TERT-BUTYL 5-((4-METHYLPIPERAZIN-1-YL)SULFONYL)-1H-INDOLE-1-CARBOXYLATE
C18H25N3O4S (379.15656900000005)
4-(4-fluorobenzoyl)piperidine p-toluenesulfonate
C19H22FNO4S (379.12535040000006)
5-AMINOPENTANOIC ACID-BENZYL ESTER P-TOSYLATE
C19H25NO5S (379.14533600000004)
Urea, N-(4-chlorophenyl)-N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]- (9CI)
Urea, N-(2-chlorophenyl)-N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]- (9CI)
Urea, N-(2-chlorophenyl)-N-[2-[(3-cyano-6-methyl-2-quinolinyl)amino]ethyl]- (9CI)
cobalt,fluoren-9-one,1,2,3,4,5-pentamethylcyclopentane
L-Valine benzyl ester p-toluenesulfonate salt
C19H25NO5S (379.14533600000004)
3,7-diphenyl-6-(pyridin-2-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine
4-methylumbelliferyl-2-acetamido-2-deoxy-alpha-d-glucopyranoside
METHYL 4-(((BENZYLOXY)CARBONYL)AMINO)-2-FLUORO-[1,1-BIPHENYL]-3-CARBOXYLATE
METHYL 4-(((BENZYLOXY)CARBONYL)AMINO)-6-FLUORO-[1,1-BIPHENYL]-3-CARBOXYLATE
4-Methylumbelliferyl-N-acetyl-beta-D-galactosaminide hydrate
6-Oxo-2-phenyl-5-[[(phenylmethoxy)carbonyl]amino]-1(6H)-pyrimidineacetic acid
1-Benzyl-N-[(benzyloxy)carbonyl]-L-histidine
C21H21N3O4 (379.15319860000005)
1,2,3-Trimethyl-1-benzyl-1H-benzo[e]indolium bromide
C22H22BrN (379.09355120000004)
(S)-Fmoc-2-amino-4,4,4-trifluoro-butyric acid
C19H16F3NO4 (379.10313720000005)
BOC-THIONOVAL-1-(6-NITRO)BENZOTRIAZOLIDE
C16H21N5O4S (379.1314186000001)
benzyltrimethylammonium 1,1,3,3,3-pentafluoro-2-hydroxypropanesulfonate
C13H18F5NO4S (379.0876648000001)
(1-methylpiperidin-4-yl) 2-chloro-2,2-diphenylacetate,hydrochloride
N-FMOC-AMINO-4-KETOCYCLOHEXYLCARBOXYLIC ACID
C22H21NO5 (379.14196560000005)
FMOC-D,L-ALPHA-AMINO-2-THIOPHENACETIC ACID
C21H17NO4S (379.08782420000006)
TERT-BUTYL 4-(5-BROMO-1H-INDAZOL-3-YL)PIPERIDINE-1-CARBOXYLATE
1H-Pyrrolo[2,3-b]pyridine-3-ethanamine, N,N-dimethyl-1-(2-naphthalenylsulfonyl)-
C21H21N3O2S (379.13544060000004)
1-(2,3-EPOXYPROPYL)-4-PHENYLPIPERAZINE
C18H25N3O4S (379.15656900000005)
4,11-diamino-2-(3-methoxypropyl)-1H-Naphth[2,3-f]isoindole-1,3,5,10(2H)-tetrone
(2R,3R,4S,5S)-2-[6-(3-bicyclo[2.2.1]heptanylamino)purin-9-yl]-5-(chloromethyl)oxolane-3,4-diol
C17H22ClN5O3 (379.1411092000001)
Tetrahydropapaverine hydrochloride
C20H26ClNO4 (379.1550266000001)
Tetrahydropapaverine hydrochloride is one of the Tetrahydroisoquinolines. Tetrahydropapaverine hydrochloride has neurotoxic effects on dopamine neurons[1][2].
6-((1-(3-FLUORO-5-(TRIFLUOROMETHYL)BENZYL)PIPERIDIN-4-YL)AMINO)PYRIDAZINE-3-CARBONITRILE
N-methyl-2-nitro-4-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxyaniline
4-(4-METHYL-5-(2-(TRIFLUOROMETHYL)PHENYL)-4H-1,2,4-TRIAZOL-3-YL)BICYCLO[2.2.2]OCTANE-1-CARBOXYLIC ACID
C19H20F3N3O2 (379.15075360000003)
4-[(2-Butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]-1,1-biphenyl-2-carbonitrile
C22H22ClN3O (379.14513120000004)
2-[4-[2-[4-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]vinyl]phenyl]benzoxazole
5-[(3-chlorophenyl)azo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-(phenylamino)nicotinonitrile
C19H14ClN5O2 (379.08359740000003)
(4-N-(Benzhydryloxycarbonyl)cytosine)-1-acetic acid
Desmethyl Erlotinib
C21H21N3O4 (379.15319860000005)
dicyclohexylamine (S)-2-hydroxy-4-(methylselanyl)butanoate
C17H33NO3Se (379.16255179999996)
(3-Chloro-5-trifluoroMethyl-3,4,5,6-tetrahydro-2H-[1,2]bipyridinyl-3-yl)-carbaMic acid tert-butyl ester
1-(2-AMINO-PHENYL)-PIPERIDIN-3-CARBAMICACIDTERT-BUYTLESTER
C21H21N3O4 (379.15319860000005)
4-Methylumbelliferyl 2-amino-2-deoxy-a-D-glucopyranoside
6-BROMO-1-(TETRAHYDRO-2H-PYRAN-2-YL)-N-(TETRAHYDRO-2H-PYRAN-4-YL)-1H-INDAZOL-3-AMINE
5-(3-((2S)-(1,4-Benzodioxan-2-ylmethyl)amino)propoxy)-1,3-benzodioxol hydrochloride
C19H22ClNO5 (379.11864320000007)
(6E)-2,5-diamino-6-[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-ylidene]hexanoic acid
C15H21N7O5 (379.16040960000004)
Fuzapladib
C15H20F3N3O3S (379.11774060000005)
C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C2144 - Endothelial-Specific Integrin/Survival Signaling Inhibitor D004791 - Enzyme Inhibitors > D064801 - Phospholipase A2 Inhibitors C308 - Immunotherapeutic Agent > C574 - Immunosuppressant Fuzapladib (IS-741), an orally active leukocyte-function-associated antigen type 1 (LFA-1) activation inhibitor, is a leukocyte adhesion molecule. Fuzapladib is also a phospholipase A2 (PLA2) inhibitor. Fuzapladib exerts anti-inflammatory effects by inhibiting leukocyte migration into the inflammatory site[1][2].
Dimethane sulfonate
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
N2,N2-dimethyl-6-[[[1-(1-naphthalenyl)-5-tetrazolyl]thio]methyl]-1,3,5-triazine-2,4-diamine
methyl 4-{3-[1-(3-nitro-2-pyridinyl)-4-piperidinyl]-1H-pyrazol-5-yl}phenyl ether
C20H21N5O3 (379.16443160000006)
gamma-Glutamyl-cysteinyl-glutamic acid
C13H21N3O8S (379.10493060000005)
6-[2-amino-5-(4-methoxyphenoxy)-1H-pyrimidin-6-ylidene]-3-(2-methylprop-2-enoxy)-1-cyclohexa-2,4-dienone
C21H21N3O4 (379.15319860000005)
2-[(4-Chlorophenyl)methyl]-6-phenyl-5-(1-piperidinyl)-3-pyridazinone
C22H22ClN3O (379.14513120000004)
2-[(3-Chlorophenyl)methyl]-6-phenyl-5-(1-piperidinyl)-3-pyridazinone
C22H22ClN3O (379.14513120000004)
5-Tert-butyl-3-(4-chlorophenyl)-7-(2-ethyl-1-imidazolyl)pyrazolo[1,5-a]pyrimidine
C21H22ClN5 (379.15636420000004)
N-(4,7-dimethyl-1,3-benzothiazol-2-yl)-4-(2,5-dioxo-1-pyrrolidinyl)benzamide
C20H17N3O3S (379.09905720000006)
4-amino-3-(4-ethoxyphenyl)-N-(2-oxolanylmethyl)-2-sulfanylidene-5-thiazolecarboxamide
2-(4-benzofuro[3,2-d]pyrimidinylthio)-N-(2-ethoxyphenyl)acetamide
C20H17N3O3S (379.09905720000006)
2-[[1-(phenylmethyl)-3-indolyl]thio]-N-(2-thiazolyl)acetamide
3-{2-[(propan-2-yl)amino]acetamido}-N-[3-(trifluoromethyl)phenyl]benzamide
C19H20F3N3O2 (379.15075360000003)
3-[Isopropyl(4-methylbenzoyl)amino]-5-phenylthiophene-2-carboxylic acid
C22H21NO3S (379.1242076000001)
1-(5-Chloro-2-Methoxyphenyl)-3-{6-[2-(Dimethylamino)-1-Methylethoxy]pyrazin-2-Yl}urea
C17H22ClN5O3 (379.1411092000001)
Pyridoxyl-glutamic acid-5-monophosphate
C13H20N2O9P+ (379.09063800000007)
[1-Propylsulfonyl-4-[[2-(trifluoromethyl)phenyl]methyl]piperidin-4-yl]methanol
C17H24F3NO3S (379.1428910000001)
beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-beta-D-GalpNAc
An amino disaccharide consisting of N-acetyl-beta-D-galactosamine having a 4-deoxy-alpha-L-threo-hex-4-enopyranuronosyl residue attached at the 3-position.
Meticillin sodium
C17H19N2O6S- (379.09637740000005)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
(2E,6E)-3,7,11-Trimethyldodeca-2,6,10-trien-1-yl diphosphate
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
1-hydroxy-3-[(2E,4E,6E)-8-methyldeca-2,4,6-trienoyl]-5-(4-oxidophenyl)-2-oxopyridin-4-olate
C22H21NO5-2 (379.14196560000005)
3,3-Dimethyl-2-oxobutyric acid 5-(6-aminopurin-9-yl)-3,4-dihydroxytetrahydrofuran-2-ylmethyl ester
C16H21N5O6 (379.14917660000003)
L-Tyr-3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-OH
(2R,3R,4S)-2-[(2R,3R,4R,5R)-5-acetamido-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid
2-[[(2R)-2-amino-3-[(E)-N-hydroxy-C-(8-methylsulfanyloctyl)carbonimidoyl]sulfanylpropanoyl]amino]acetic acid
5-amino-2-(1-ethylpropyl)-6-[(Z)-(2-methylindol-3-ylidene)methyl]-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-one
C20H21N5OS (379.14667360000004)
6-(4-fluoro-1,3-benzodioxol-5-yl)-N-(thiophen-2-ylmethyl)-4-quinazolinamine
1-Benzimidazolyl-[2-(4-methoxyphenyl)-4-quinolinyl]methanone
N-[1-(2-chloro-6-fluorobenzyl)-4-piperidinyl]-N-(4-fluorophenyl)urea
1-[4-(4-Phenoxyphenyl)-2-thiazolyl]-4-piperidinecarboxamide
C21H21N3O2S (379.13544060000004)
Tyr-FMDP
A dipeptide composed of 3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanine and L-tyrosine joined by peptide linkages.
5-(3,4-Dimethoxyphenyl)-2-(4-methylphenyl)-4-thieno[2,3-d][1,3]oxazinone
C21H17NO4S (379.08782420000006)
N-[1-(2-methoxyphenyl)-5-benzimidazolyl]benzenesulfonamide
C20H17N3O3S (379.09905720000006)
N-[4-(diethylamino)-2-methylphenyl]-2-[(2-nitro-3-thiophenyl)thio]acetamide
N-(4-oxo-2-phenyl-1,2-dihydroquinazolin-3-yl)benzenesulfonamide
C20H17N3O3S (379.09905720000006)
2-(2-chlorophenyl)-9-(3-methylphenyl)-8-oxo-7H-purine-6-carboxamide
C19H14ClN5O2 (379.08359740000003)
4-(2,5-dimethoxyphenyl)-3-(3-phenyl-1H-pyrazol-5-yl)-1H-1,2,4-triazole-5-thione
2-(5-chloro-2-pyridinyl)-3-(4-ethoxyanilino)-3H-isoindol-1-one
2-[[2-(3,4-dihydro-2H-quinolin-1-yl)-2-oxoethyl]thio]-3-ethyl-4-quinazolinone
C21H21N3O2S (379.13544060000004)
(5E)-3-[(2-fluorophenyl)methyl]-5-[[1-(4-fluorophenyl)pyrrol-2-yl]methylidene]imidazolidine-2,4-dione
1-(2,3-Dihydroindol-1-yl)-2-[(4-propyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)thio]ethanone
C20H21N5OS (379.14667360000004)
2-[[5-(6-methyl-1H-benzimidazol-2-yl)-2-pyridinyl]thio]-N-(5-methyl-3-isoxazolyl)acetamide
4-(1-methylsulfonyl-2,3-dihydroindol-5-yl)-N-(2-oxolanylmethyl)-2-thiazolamine
1-(12-oxo-7,8,9,10-tetrahydro-6H-azepino[2,1-b]quinazolin-2-yl)-3-(3-pyridinylmethyl)thiourea
C20H21N5OS (379.14667360000004)
1-[2-(4-Methylphenyl)-3-indolizinyl]-2-[(5-methyl-1,3,4-thiadiazol-2-yl)thio]ethanone
(2S,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2R,3S,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2R,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2R,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2S,3S,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2S,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2R,3S,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile
N-(2-chloroethyl)-N-(6-chloro-2-methoxyacridin-9-yl)propane-1,3-bis(aminium)
N-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]-1,3-benzodioxole-5-carboxamide
C19H13N3O6 (379.08043180000004)
(R)-S-Lactoylglutathione
C13H21N3O8S (379.10493060000005)
The S-[(R)-lactoyl] derivative of glutathione. It is an intermediate in the pyruvate metabolism. D000970 - Antineoplastic Agents
Gonyautoxin V
D009676 - Noxae > D011042 - Poisons > D008978 - Mollusk Venoms D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D011042 - Poisons > D014688 - Venoms
3-(4-Deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-2-acetamido-2-deoxy-D-glucose
N-acetyl-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-D-galactosamine
2-({6-Amino-3,5-dicyano-4-[4-(cyclopropylmethoxy)phenyl]pyridin-2-yl}sulfanyl)acetamide
D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058913 - Purinergic Agonists BAY 60-6583 is a potent and high-affinity agonist of adenosine A2B receptor (EC50?= 3 nM) over A1, A2A, and A3 receptors. BAY 60-6583 binds to mouse, rabbit, and dog A2BAR with Ki values of 750 nM, 340 nM and 330 nM, respectively. BAY 60-6583 has a cardioprotective effect in a myocardial ischemia model[1][5].
2-methylthio-N(6)-(cis-4-hydroxy-Delta(2)-isopentenyl)adenosine residue
C16H21N5O4S (379.1314186000001)
A nucleoside residue in which an adenosine residue has been modified by substitution at C-2 by a methylthio (methylsulfanyl) group and at the 6-amino nitrogen by a cis-4-hydroxy-Delta(2)-isopentenyl group.
beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-beta-D-GlcpNAc
An amino disaccharide consisting of N-acetyl-beta-D-glucosamine having a 4-deoxy-alpha-L-threo-hex-4-enopyranuronosyl residue attached at the 3-position.
N(6)-dansyl-L-lysine
C18H25N3O4S (379.15656900000005)
An L-lysine derivative with a dansyl group at the N(6)-position.
3-(4-deoxy-beta-D-gluc-4-enosyluronic acid)-N-acetyl-D-glucosamine
An amino disaccharide consisting of N-acetyl-beta-D-glucosamine having a 4-deoxy-alpha-L-threo-hex-4-enopyranuronosyl residue attached at the 3-position.
2-trans,6-trans-farnesyl diphosphate(3-)
An organophosphate oxoanion that is the trianion obtained by removal of the three protons from the diphosphate group of 2-trans,6-trans-farnesyl diphosphate.
ML381
C21H21N3O4 (379.15319860000005)
ML381 (VU0488130) is a highly selective, central nervous system penetrant mAChR M5 orthogonal antagonist (IC50 = 450 nM; Ki = 340 nM). ML381 is unstable in rat plasma and can be mainly used as a molecular probe for in vitro and electrophysiological studies[1][2].
(10e)-9-methyl-10-(phenylmethylidene)-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,11,13,15,17-heptaene-8,19-dione
(1r,4r,7s,11z,18s)-4-ethyl-7,14,18-trimethyl-2,6,9-trioxa-14-azatricyclo[9.5.1.1⁴,⁷]octadec-11-ene-3,5,8,17-tetrone
2,3,7,8-tetramethoxy-5-methylbenzo[c]phenanthridin-6-one
C22H21NO5 (379.14196560000005)
(8z)-1,10-dihydroxy-8-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3-oxa-6,9-diazatricyclo[4.4.0.0²,⁴]dec-9-en-7-one
C21H21N3O4 (379.15319860000005)
(3s)-3-[(1r)-1-[(2s,5s)-3,6-dihydroxy-5-[(s)-methanesulfinylmethyl]-2,5-dihydropyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one
C17H21N3O5S (379.12018560000007)
3-(1-hydroxyethyl)-6-(1h-indol-3-ylmethyl)-3,6-bis(methylsulfanyl)pyrazine-2,5-diol
n-sulfo{[(3as,4r,10as)-10,10-dihydroxy-2,6-diimino-hexahydro-1h-pyrrolo[1,2-c]purin-4-yl]methoxy}carboximidic acid
4-(3,4-dihydroxyphenyl)-2-(5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl)-2-(4-hydroxyphenyl)cyclopent-4-ene-1,3-dione
(2s)-2-amino-4-{[(1r)-1-(carboxymethyl-c-hydroxycarbonimidoyl)-2-{[(2r)-2-hydroxypropanoyl]sulfanyl}ethyl]-c-hydroxycarbonimidoyl}butanoic acid
C13H21N3O8S (379.10493060000005)
[(20r)-17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl]methanol
C22H21NO5 (379.14196560000005)
(20s)-17,18,20-trimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaene
C22H21NO5 (379.14196560000005)
5-hydroxy-6-(hydroxymethyl)-3-(1h-indol-3-ylmethyl)-1-methyl-3,6-bis(methylsulfanyl)pyrazin-2-one
[(3as,4r,9s,10s,10as)-10-hydroxy-2,6-diimino-9-(sulfooxy)-octahydropyrrolo[1,2-c]purin-4-yl]methoxycarboximidic acid
1-hydroxy-12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-2,14,20-trione
C21H21N3O4 (379.15319860000005)
[(3ar,4r,9s,10s,10as)-4-[(carbamoyloxy)methyl]-10-hydroxy-2,6-diimino-octahydropyrrolo[1,2-c]purin-9-yl]oxidanesulfonic acid
6-(3,7-dimethylocta-2,6-dien-1-yl)-7-methoxy-3,4-dihydro-2h-1λ⁶,4-benzothiazine-1,1,5,8-tetrone
C19H25NO5S (379.14533600000004)
11,17,18-trimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaene
C22H21NO5 (379.14196560000005)
3-{1-[3,6-dihydroxy-5-(methanesulfinylmethyl)-2,5-dihydropyrazin-2-yl]ethyl}-3-hydroxy-1-methylindol-2-one
C17H21N3O5S (379.12018560000007)
3-hydroxy-4,5-dimethoxy-6-[2-(5-oxohexyl)-1,3-thiazol-4-yl]pyridine-2-carboximidic acid
C17H21N3O5S (379.12018560000007)
5-hydroxy-4-{[(3s)-3-hydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl]methyl}-3-(4-hydroxyphenyl)pyrrol-2-one
C22H21NO5 (379.14196560000005)
(3s,6r)-5-hydroxy-3-(hydroxymethyl)-6-(1h-indol-3-ylmethyl)-1-methyl-3,6-bis(methylsulfanyl)pyrazin-2-one
(3s)-3-[(1r)-1-[(2s,5s)-3,6-dihydroxy-5-[(r)-methanesulfinylmethyl]-2,5-dihydropyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one
C17H21N3O5S (379.12018560000007)
6-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-7-methoxy-3,4-dihydro-2h-1λ⁶,4-benzothiazine-1,1,5,8-tetrone
C19H25NO5S (379.14533600000004)
15,17,18-trimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaene
C22H21NO5 (379.14196560000005)
(n'-{5-amino-2-methyl-6-[(2,3,4,5,6-pentahydroxycyclohexyl)oxy]oxan-3-yl}carbamimidoyl)formic acid
C14H25N3O9 (379.15907200000004)
(6s,7r)-4-(methoxycarbonyl)-7-methyl-5h,6h,7h-cyclopenta[c]pyridin-6-yl (1r)-1-methyl-1,2-dihydro-2,7-naphthyridine-4-carboxylate
C21H21N3O4 (379.15319860000005)
9,17-dihydroxy-5,11,15,16,16-pentamethyl-14-oxa-4-azapentacyclo[10.6.1.0³,⁷.0⁸,¹⁹.0¹³,¹⁷]nonadeca-1(19),3(7),5,8,10,12-hexaene-2,18-dione
C22H21NO5 (379.14196560000005)
(3r)-3-[(1r)-1-[(2s,5r)-3,6-dihydroxy-5-[(r)-methanesulfinylmethyl]-2,5-dihydropyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one
C17H21N3O5S (379.12018560000007)
(2r)-4-(3,4-dihydroxyphenyl)-2-[(2r)-5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl]-2-(4-hydroxyphenyl)cyclopent-4-ene-1,3-dione
(3s,6s)-5-hydroxy-6-(hydroxymethyl)-3-(1h-indol-3-ylmethyl)-1-methyl-3,6-bis(methylsulfanyl)pyrazin-2-one
9-methyl-10-(phenylmethylidene)-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,11,13,15,17-heptaene-8,19-dione
(23s)-12-methoxy-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-ol
5-hydroxy-3-(4-hydroxyphenyl)-4-{[(2r)-2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-yl]methyl}pyrrol-2-one
C22H21NO5 (379.14196560000005)
(2s,5r,6r,6as)-5-(6-aminopurin-9-yl)-2-[carboxy(hydroxy)methyl]-6-hydroxy-5h,6h,6ah-furo[3,2-b]furan-2-carboxylic acid
(4s,5r,6r)-6-{[(3r,4r,5r,6r)-2,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-4-yl]oxy}-4,5-dihydroxy-5,6-dihydro-4h-pyran-2-carboxylic acid
(20r)-17,18,20-trimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaene
C22H21NO5 (379.14196560000005)
1-[(1r,12s,22r)-23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.9.2.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaen-22-yl]propan-2-one
C22H21NO5 (379.14196560000005)
4-ethyl-7,14,18-trimethyl-2,6,9-trioxa-14-azatricyclo[9.5.1.1⁴,⁷]octadec-11-ene-3,5,8,17-tetrone
n-{2-[12-methoxy-11-(methylsulfanyl)-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,9,11,13,15-octaen-10-yl]ethyl}ethanimidic acid
C21H21N3O2S (379.13544060000004)
12-methoxy-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-ol
(3r)-3-[(1r)-1-[(2s,5r)-3,6-dihydroxy-5-[(s)-methanesulfinylmethyl]-2,5-dihydropyrazin-2-yl]ethyl]-3-hydroxy-1-methylindol-2-one
C17H21N3O5S (379.12018560000007)
(2r,5r,6r,6ar)-5-(6-aminopurin-9-yl)-2-[(s)-carboxy(hydroxy)methyl]-6-hydroxy-5h,6h,6ah-furo[3,2-b]furan-2-carboxylic acid
3-hydroxy-4,5-dimethoxy-6-[2-(4-oxohexyl)-1,3-thiazol-4-yl]pyridine-2-carboximidic acid
C17H21N3O5S (379.12018560000007)
(3s,6r)-5-hydroxy-6-(hydroxymethyl)-3-(1h-indol-3-ylmethyl)-1-methyl-3,6-bis(methylsulfanyl)pyrazin-2-one
2-{[(2s)-2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-{[(2e)-1-hydroxy-4-methoxy-4-oxobut-2-en-1-ylidene]amino}propanoic acid
3-hydroxy-4,5-dimethoxy-6-[2-(3-methyl-4-oxopentyl)-1,3-thiazol-4-yl]pyridine-2-carboximidic acid
C17H21N3O5S (379.12018560000007)
(1r,12s,15s)-1-hydroxy-12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-2,14,20-trione
C21H21N3O4 (379.15319860000005)
(15s,17s)-9,17-dihydroxy-5,11,15,16,16-pentamethyl-14-oxa-4-azapentacyclo[10.6.1.0³,⁷.0⁸,¹⁹.0¹³,¹⁷]nonadeca-1(19),3(7),5,8,10,12-hexaene-2,18-dione
C22H21NO5 (379.14196560000005)
(3s,6s)-3-[(1s)-1-hydroxyethyl]-6-(1h-indol-3-ylmethyl)-3,6-bis(methylsulfanyl)pyrazine-2,5-diol
{17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl}methanol
C22H21NO5 (379.14196560000005)
1-{23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.9.2.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaen-22-yl}propan-2-one
C22H21NO5 (379.14196560000005)
{n'-[(2r,3s,5s,6r)-5-amino-2-methyl-6-{[(2r,3s,5s,6s)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}oxan-3-yl]carbamimidoyl}formic acid
C14H25N3O9 (379.15907200000004)
n-sulfo({10,10-dihydroxy-2,6-diimino-hexahydro-1h-pyrrolo[1,2-c]purin-4-yl}methoxy)carboximidic acid
4-(methoxycarbonyl)-7-methyl-5h,6h,7h-cyclopenta[c]pyridin-6-yl 1-methyl-1,2-dihydro-2,7-naphthyridine-4-carboxylate
C21H21N3O4 (379.15319860000005)